LRRK2 and Parkinson disease: In contrast, mitophagy levels were above baseline levels in less-sensitive sporadic PD lines (p < 0.001) and healthy subject controls (p < 0.001) with the addition of LRRK2-in-1 (Fig. 5a, c).